Sequence Analysis

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Genomics
GenomicsUK - Oxford
1 program
non interventionN/A1 trial
Active Trials
NCT03719222Unknown600Est. Sep 2019
ACT Genomics
ACT GenomicsTaiwan - Taipei
1 program
non interventionN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Genomicsnon intervention

Clinical Trials (1)

Total enrollment: 600 patients across 1 trials

NCT03719222Genomicsnon intervention

Analysis of Tumor Mutations and Tumor Microenvironment Using Archival Paraffin-embedded Tumor Specimens

Start: Sep 2018Est. completion: Sep 2019600 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space